Effect of almond consumption on vascular function in patients with coronary artery disease: A randomized, controlled, cross-over trial

Nutrition Journal

Volumn 14, Issue 1, 2015, Pages

  Chen, C Y Oliver ^a   Holbrook, Monika ^b   Duess, Mai Ann ^b   Dohadwala, Mustali M ^b   Hamburg, Naomi M ^b   Asztalos, Bela F ^a   Milbury, Paul E ^a   Blumberg, Jeffrey B ^a   Vita, Joseph A ^b  

^a TUFTS UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Almonds; Coronary arterial disease; Dietary quality; Endothelial function; Inflammation; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; C REACTIVE PROTEIN; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; SELE PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADULT; ALMOND; ARTERY TONE; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; BLOOD VESSEL FUNCTION; CALCIUM INTAKE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLINE INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DIET THERAPY; DIETARY REFERENCE INTAKE; FEMALE; FIBER INTAKE; FOOD INTAKE; HUMAN; LIPID BLOOD LEVEL; MAGNESIUM INTAKE; MALE; PATIENT COMPLIANCE; PROTEIN BLOOD LEVEL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; URINE LEVEL; VASCULITIS; VASODILATATION; VITAMIN BLOOD LEVEL; AGED; BLOOD; CALORIC INTAKE; FOOD QUALITY; MASSACHUSETTS; MIDDLE AGED; NUTRITIONAL ASSESSMENT; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; QUESTIONNAIRE; URINE; VERY ELDERLY; YOUNG ADULT;

PRUNUS DULCIS;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-TOCOPHEROL; BIOMARKERS; BOSTON; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; CROSS-OVER STUDIES; E-SELECTIN; ENERGY INTAKE; FEMALE; FOOD QUALITY; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; NITRIC OXIDE; NUTRITION ASSESSMENT; NUTRITIONAL REQUIREMENTS; NUTRITIONAL STATUS; PRUNUS DULCIS; PULSE WAVE ANALYSIS; SURVEYS AND QUESTIONNAIRES; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1; YOUNG ADULT;

EID: 84935832175     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/s12937-015-0049-5     Document Type: Article

References (48)

1. World Health Organization. The top 10 causes of death - Major causes of death [ http://www.who.int/mediacentre/factsheets/fs310/en/index2.html ]
2. Booth 3rd JN, Levitan EB, Brown TM, Farkouh ME, Safford MM, Muntner P. Effect of Sustaining Lifestyle Modifications (Nonsmoking, Weight Reduction, Physical Activity, and Mediterranean Diet) After Healing of Myocardial Infarction, Percutaneous Intervention, or Coronary Bypass (from the REasons for Geographic and Racial Differences in Stroke Study). Am J Cardiol. 2014;113:1933-40.
3. Keys A. Diet and the epidemiology of coronary heart disease. JAMA. 1957;164:1912-9.
4. Dalen JE, Devries S. Diets to prevent coronary heart disease 1957-2013: what have we learned- Am J Med. 2014;127:364-9.
5. Jenkins DJ, Jones PJ, Lamarche B, Kendall CW, Faulkner D, Cermakova L, et al. Effect of a dietry portfolio of cholesterol-lowering foods given a 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: A randomized controlled trial. JAMA. 2011;306:831-9.
6. American Heart Association's Diet and Lifestyle Recommendations. [ http://www.heart.org/HEARTORG/GettingHealthy/NutritionCenter/HealthyEating/The-American-Heart-Associations-Diet-and-Lifestyle-Recommendations-UCM-305855-Article.jsp ]
7. De Lorgeril M, Salen P, Martin JL, Mamelle N, Monjaud I, Touboul P, et al. Effect of a mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease. Insights into the cardioprotective effect of certain nutriments. J Am Coll Cardiol. 1996;28:1103-8.
8. Kris-Etherton PM, Zhao G, Binkoski AE, Coval SM, Etherton TD. The effect of nuts on coronary heart disease risk. Nutr Rev. 2001;59:103-11.
9. Ros E, Hu FB. Consumption of plant seeds and cardiovascular health: epidemiological and clinical trial evidence. Circulation. 2013;128:553-65.
10. Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279-90.
11. Kamil A, Chen CY. Health benefits of almonds beyond cholesterol reduction. J Agric Food Chem. 2012;60:6694-702.
12. Griel AE, Kris-Etherton PM. Tree nuts and the lipid profile: a review of clinical studies. Br J Nutr. 2006;96 Suppl 2:68-78.
13. Choudhury K, Clark J, Griffiths HR. An almond-enriched diet increases plasma α-tocopherol and improves vascular function but does not affect oxidative stress markers or lipid levels. Free Radic Res. 2014;48:599-606.
14. Gokce N, Holbrook M, Hunter LM, Palmisano J, Vigalok E, Keaney Jr JF, et al. Acute effects of vasoactive drug treatment on brachial artery reactivity. J Am Coll Cardiol. 2002;40:761-5.
15. Jenkins DJ, Kendall CW, Marchie A, Parker TL, Connelly PW, Qian W, et al. Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial. Circulation. 2002;106:1327-32.
16. Dohadwala MM, Holbrook M, Hamburg NM, Shenouda SM, Chung WB, Titas M, et al. Effects of cranberry juice consumption on vascular function in patients with coronary artery disease. Am J Clin Nutr. 2011;93:934-40.
17. Vita JA. Nitric oxide-dependent vasodilation in human subjects. Methods Enzymol. 2002;359:186-200.
18. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257-65.
19. Ameho CK, Chen CY, Smith D, Sánchez-Moreno C, Milbury PE, Blumberg JB. Antioxidant activity and metabolite profile of quercetin in vitamin-E-depleted rats. J Nutr Biochem. 2008;19:467-74.
20. Willett WC, Hu FB. The food frequency questionnaire. Cancer Epidemiol Biomarkers Prev. 2007;16:182-3.
21. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-95.
22. López-Uriarte P, Nogués R, Saez G, Bulló M, Romeu M, Masana L, et al. Effect of nut consumption on oxidative stress and the endothelial function in metabolic syndrome. Clin Nutr. 2010;29:373-80.
23. Orem A, Yucesan FB, Orem C, Akcan B, Kural BV, Alasalvar C, et al. Hazelnut-enriched diet improves cardiovascular risk biomarkers beyond a lipid-lowering effect in hypercholesterolemic subjects. J Clin Lipidol. 2013;7:123-31.
24. Katz DL, Davidhi A, Ma Y, Kavak Y, Bifulco L, Njike VY. Effects of walnuts on endothelial function in overweight adults with visceral obesity: a randomized, controlled, crossover trial. J Am Coll Nutr. 2012;31:415-23.
25. Ros E, Nunez I, Perez-Heras A, Serra M, Gilabert R, Casals E, et al. A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation. 2004;109:1609-14.
26. Li SC, Liu YH, Liu JF, Chang WH, Chen CM, Chen CY. Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus. Metabolism. 2011;60:474-9.
27. Damasceno NR, Pérez-Heras A, Serra M, Cofán M, Sala-Vila A, Salas-Salvadó J, et al. Crossover study of diets enriched with virgin olive oil, walnuts or almonds. Effects on lipids and other cardiovascular risk markers. Nutr Metab Cardiovasc Dis. 2011;21 Suppl 1:S14-20.
28. Jalali-Khanabadi BA, Mozaffari-Khosravi H, Parsaeyan N. Effects of almond dietary supplementation on coronary heart disease lipid risk factors and serum lipid oxidation parameters in men with mild hyperlipidemia. J Altern Complement Med. 2010;16:1279-83.
29. Wien M, Bleich D, Raghuwanshi M, Gould-Forgerite S, Gomes J, Monahan-Couch L, et al. Almond consumption and cardiovascular risk factors in adults with prediabetes. J Am Coll Nutr. 2010;29:189-97.
30. Jaceldo-Siegl K, Sabaté J, Batech M, Fraser GE. Influence of body mass index and serum lipids on the cholesterol-lowering effects of almonds in free-living individuals. Nutr Metab Cardiovasc Dis. 2011;21 Suppl 1:7-13.
31. Sabaté J, Haddad E, Tanzman JS, Jambazian P, Rajaram S. Serum lipid response to the graduated enrichment of a Step I diet with almonds: a randomized feeding trial. Am J Clin Nutr. 2003;77:1379-84.
32. Hyson DA, Schneeman BO, Davis PA. Almonds and almond oil have similar effects on plasma lipids and LDL oxidation in healthy men and women. J Nutr. 2002;132:703-7.
33. Nishi S, Kendall CW, Gascoyne AM, Bazinet RP, Bashyam B, Lapsley KG, et al. Effect of almond consumption on the serum fatty acid profile: a dose-response study. Br J Nutr. 2014;20:1-10.
34. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-74.
35. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557-65.
36. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363-9.
37. Hope SA, Meredith IT. Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction. Intern Med J. 2003;33:450-62.
38. Jiang R, Jacobs Jr DR, Mayer-Davis E, Szklo M, Herrington D, Jenny NS, et al. Nut and seed consumption and inflammatory markers in the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2006;163:222-31.
39. Liu JF, Liu YH, Chen CM, Chang WH, Chen CY. The effect of almonds on inflammation and oxidative stress in Chinese patients with type 2 diabetes mellitus: a randomized crossover controlled feeding trial. Eur J Nutr. 2013;52:927-35.
40. Rajaram S, Connell KM, Sabaté J. Effect of almond-enriched high-monounsaturated fat diet on selected markers of inflammation: a randomised, controlled, crossover study. Br J Nutr. 2010;103:907-12.
41. Tehrani DM, Gardin JM, Yanez D, Hirsch CH, Lloyd-Jones DM, Stein PK, et al. Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: cardiovascular Health Study. Atherosclerosis. 2013;231:246-51.
42. USDA Full Report (All Nutrients): 12061, Nuts, almonds [ http://ndb.nal.usda.gov/ndb/foods/show/3667-fg=&man=&lfacet=&count=&max=35&sort=&qlookup=almond&offset=&format=Full&new=&measureby= ]
43. Bolling BW, Chen CY, McKay DL, Blumberg JB. Tree nut phytochemicals: composition, antioxidant capacity, bioactivity, impact factors. A systematic review of almonds, Brazils, cashews, hazelnuts, macadamias, pecans, pine nuts, pistachios and walnuts. Nutr Res Rev. 2011;24:244-75.
44. Jaceldo-Siegl K, Sabaté J, Rajaram S, Fraser GE. Long-term almond supplementation without advice on food replacement induces favourable nutrient modifications to the habitual diets of free-living individuals. Br J Nutr. 2004;92:533-40.
45. Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med. 2002;113(Suppl 9B):71-88.
46. Vauzour D, Rodriguez-Mateos A, Corona G, Oruna-Concha MJ, Spencer JP. Polyphenols and human health: prevention of disease and mechanisms of action. Nutrients. 2010;2:1106-31.
47. Vita JA. Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr. 2005;81 Suppl 1:292-7.
48. Berryman CE, Preston AG, Karmally W, Deckelbaum RJ, Kris-Etherton PM. Effects of almond consumption on the reduction of LDL-cholesterol: a discussion of potential mechanisms and future research directions. Nutr Rev. 2011;69:171-85.